Fluticasona en diferentes dosis para el asma crónica en adultos y niños
Información
- DOI:
- https://doi.org/10.1002/14651858.CD003534.pub3Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 08 octubre 2008see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Review
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Vías respiratorias
- Copyright:
-
- Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
Nick Adams retrieved papers identified by the electronic search, handsearched additional sources for relevant studies, assessed trials for methodological quality, contacted authors to clarify details of trial design and/or request missing data, extracted data from included trials and wrote the text of the review.
Janine Bestall retrieved papers identified by the search, assessed trials for methodological quality, contacted authors for clarification of trial details and/or to request missing data.
Paul Jones provided editorial support.
Toby Lasserson and Benedict Griffiths assisted with study selection, study assessment, data extraction, data entry and analysis, and interpretation and writing of the update of the review, in November 2004, and August 2008.
Chris Cates provided methodological support and guidance with the content for the November 2004 and August 2008 updates.
Sources of support
Internal sources
-
No sources of support supplied
External sources
-
NHS Research and Development, UK.
-
Garfield Weston Foundation, UK.
Declarations of interest
None known.
Acknowledgements
We would like to thank the support staff of the Cochrane Airways Group, Liz Arnold, Anna Bara and Jane Dennis for assistance in the electronic search and retrieval of papers and Steve Milan for statistical support. We would like to thank the authors who were kind enough to provide extra details concerning their studies, including Professor DB Allen, Professor JG Ayres, Professor R Dahl, Professor E Derom, Dr Y Katz and Dr AL Sheffer. We would like to thank Julia Earnshaw and Karen Richardson who co‐coordinated efforts on behalf of Glaxo Smith Kline to search for additional studies and who provided further information regarding a number of included studies that were sponsored by the company. We are grateful to the Nederlands Astma Fonds who provided a grant which enabled us to maintain this review. We are grateful to Janet Wale who copy‐edited this review.
Version history
| Published | Title | Stage | Authors | Version |
| 2008 Oct 08 | Fluticasone at different doses for chronic asthma in adults and children | Review | Nick P Adams, Janine C Bestall, Paul Jones, Toby J Lasserson, Benedict Griffiths, Christopher J Cates | |
| 2005 Jul 20 | Fluticasone at different doses for chronic asthma in adults and children | Review | Nick P Adams, Janine C Bestall, Paul Jones, Toby J Lasserson, Benedict Griffiths, Christopher J Cates | |
| 2000 Oct 23 | Inhaled fluticasone at different doses for chronic asthma | Review | Nick P Adams, Janine C Bestall, Paul W Jones | |
Differences between protocol and review
We have opted against pooling data from studies in adults and children where outcomes are reported as litres (such as FEV1 and PEF). Heterogeneity in lung function outcomes such as FEV1 and PEF, are likely to be explained by differences in lung volume between these age groups since lower lung volumes in children may naturally yield results to those given by adults. However where metrics convert litres to percent predicted, and take into account age (as well as height and gender) we have retained combined estimates for adult and paediatric studies.
